OppenheimerFunds’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$22.3M	Sell	349,581 -21,966	-6%	-$1.25M	0.03%	504
2018 Q4	$19M	Buy	371,547 +35,142	+10%	+$1.78M	0.03%	527
2018 Q3	$19.5M	Sell	336,405 -147,405	-30%	-$7.21M	0.02%	589
2018 Q2	$23.5M	Buy	483,810 +26,052	+6%	+$1.22M	0.03%	540
2018 Q1	$21.3M	Buy	457,758 +444,009	+3,229%	+$19.3M	0.03%	550
2017 Q4	$517K	Sell	13,749 -504,150	-97%	-$18.5M	﹤0.01%	1507
2017 Q3	$18.9M	Sell	517,899 -227,757	-31%	-$8.69M	0.02%	582
2017 Q2	$29.4M	Sell	745,656 -192,834	-21%	-$7.04M	0.04%	434
2017 Q1	$29.4M	Sell	938,490 -465,765	-33%	-$14.6M	0.04%	452
2016 Q4	$43.9M	Buy	1,404,255 +531,966	+61%	+$17.2M	0.06%	352
2016 Q3	$35.1M	Buy	872,289 +20,019	+2%	+$754K	0.04%	415
2016 Q2	$28.3M	Sell	852,270 -480,645	-36%	-$16.4M	0.04%	463
2016 Q1	$39.2M	Buy	1,332,915 +465,870	+54%	+$12.9M	0.05%	378
2015 Q4	$22.8M	Buy	867,045 +95,325	+12%	+$2.48M	0.03%	527
2015 Q3	$18.3M	Buy	771,720 +82,980	+12%	+$2M	0.02%	568
2015 Q2	$16.4M	Sell	688,740 -218,460	-24%	-$4.93M	0.02%	637
2015 Q1	$21.5M	Buy	907,200 +46,020	+5%	+$1.03M	0.02%	575
2014 Q4	$18.3M	Buy	861,180 +144,960	+20%	+$2.91M	0.02%	608
2014 Q3	$12.2M	Buy	+716,220	New	+$11.3M	0.01%	700